Trial
NCT00233207
IC14 Antibodies to Treat Individuals With Acute Lung Injury
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Respiratory Distress Syndrome, Adult
Intervention
IC14
Why stopped
Unable to meet enrollment number to complete study, study stopped June 30, 2007
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-16